back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-18 16:38 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,270
+707 vol $6.04 each |
4,017 | |
| Filed 2025-06-17 16:16 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$29,398
+4,734 vol $6.21 each |
13,598 | |
| Filed 2025-06-17 16:12 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$29,398
+4,734 vol $6.21 each |
13,598 | |
| Filed 2025-03-29 16:40 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
||
| Filed 2025-03-29 16:39 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
||
| Filed 2025-03-29 16:40 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
12,770 | |
| Filed 2025-03-29 16:39 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,256
+3,906 vol $6.21 each |
12,770 | |
| Filed 2025-03-20 15:57 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,440
+1,077 vol $5.98 each |
3,310 | |
| Filed 2024-12-18 12:24 Tx date 2024-12-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,207
+803 vol $5.24 each |
2,233 | |
| Filed 2024-09-18 14:21 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,189
+710 vol $5.90 each |
1,430 | |
| Filed 2024-06-19 21:11 Tx date 2024-06-15 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,168
+720 vol $5.79 each |
720 | |
| Filed 2024-06-19 21:11 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:56 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$22,452
+3,939 vol $5.70 each |
8,864 | |
| Filed 2024-04-16 18:55 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$22,452
+3,939 vol $5.70 each |
8,864 | |
| Filed 2023-11-13 14:39 Tx date 2023-11-10 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,871
+4,925 vol $5.05 each |
4,925 | |
| Filed 2023-11-13 14:38 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-13 14:36 Tx date 2023-11-10 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,871
+4,925 vol $5.05 each |
4,925 | |
| Filed 2023-11-13 14:32 Tx date 2023-09-18 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|